LIFECORE BIOMEDICAL INC (LFCR) competitors & alternatives
Health Care · NASDAQ
LIFECORE BIOMEDICAL INC (LFCR)'s top competitors and alternatives — its most similar public companies — include Thermo Fisher Scientific (TMO), AptarGroup (ATR), TRISALUS LF SC CM A (TLSI), SPYGLASS PHARMA INC SHS (SGP), EMERGENT BIOSOLUTIONS INC (EBS), Charles River Laboratories (CRL), AMPHASTAR PHARMACEUTICALS INC (AMPH), MACROGENICS INC (MGNX), CODEXIS INC (CDXS), UFP TECHNOLOGIES INC (UFPT), AMNEAL PHARMACEUTICALS INC CLASS A (AMRX) and Steris (STE). These are LIFECORE BIOMEDICAL INC's closest public-company peers by sub-industry, sector and business themes and is informational only — not financial advice.
Top LFCR competitors & alternatives
-
Thermo Fisher ScientificTMOHealth Care
Thermo Fisher Scientific is a leading global provider of mission-critical laboratory equipment, analytical instrumentation, and scientific services for…
$526.46 (as of 2026-07-22) · market cap $194.1B
-
AptarGroupATRMaterials
Global manufacturer of specialized dispensing, dosing, and packaging technologies serving pharmaceutical, beauty, personal care, and food/beverage markets with…
$129.17 (as of 2026-07-22) · market cap $8.2B
-
TRISALUS LF SC CM ATLSIHealth Care
TriSalus is a medical technology company integrating proprietary pressure-enabled drug delivery devices with immunotherapeutics to improve outcomes for…
$4.24 (as of 2026-07-22) · market cap $267M
-
SPYGLASS PHARMA INC SHSSGPHealth Care
Spyglass Pharma is a clinical-stage biotech developing an innovative sustained-release drug delivery platform to improve patient outcomes in cataract surgery.
$20.54 (as of 2026-07-22) · market cap $682M
-
EMERGENT BIOSOLUTIONS INCEBSHealth Care
Emergent BioSolutions is a specialized biopharmaceutical firm that provides critical medical countermeasures and manufacturing services to protect against…
$7.58 (as of 2026-07-22) · market cap $393M
-
Charles River LaboratoriesCRLHealth Care
A global contract research organization providing non-clinical drug development services, research models, and manufacturing solutions across discovery, safety…
$218.70 (as of 2026-07-22) · market cap $10.6B
-
AMPHASTAR PHARMACEUTICALS INCAMPHHealth Care
Amphastar manufactures technically complex generic and proprietary injectable, inhalation, and intranasal drugs with high barriers to entry, leveraging…
$19.30 (as of 2026-07-22) · market cap $864M
-
MACROGENICS INCMGNXHealth Care
Clinical-stage biopharmaceutical company developing innovative antibody-based cancer therapeutics using proprietary DART, TRIDENT, and ADC platforms.
$4.30 (as of 2026-07-22) · market cap $289M
-
CODEXIS INCCDXSHealth Care
Codexis leverages its proprietary directed evolution technology to engineer high-performance enzymes that optimize the manufacturing of small molecule and…
$2.06 (as of 2026-07-22) · market cap $200M
-
UFP TECHNOLOGIES INCUFPTHealth Care
A specialized contract manufacturer producing custom single-use and single-patient medical devices for major OEMs across minimally invasive surgery, wound…
$237.96 (as of 2026-07-22) · market cap $1.9B
-
AMNEAL PHARMACEUTICALS INC CLASS AAMRXHealth Care
Amneal Pharmaceuticals is a diversified biopharma company providing a broad range of essential, affordable generic and specialty medicines, alongside…
$17.75 (as of 2026-07-22) · market cap $5.7B
-
SterisSTEHealth Care
STERIS is a global provider of infection prevention and procedural care products and services that help healthcare and life science organizations create a…
$210.57 (as of 2026-07-22) · market cap $20.6B
Not quite? Describe exactly what you want →
Peers are LIFECORE BIOMEDICAL INC's closest public companies by shared sub-industry, sector and business themes. See the full profile: LIFECORE BIOMEDICAL INC (LFCR).
Last updated 2026-07-22.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.